Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Net Cash Flow (2024 - 2025)

Updated

Innocan Pharma's Net Cash Flow came in at $15,000 for the quarter ended Sep 30, 2025, compared with -$150,000 a year earlier and down 98.2% from the prior quarter.

Analysis

Innocan Pharma (INNPF) Net Cash Flow (2024 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Innocan Pharma reported Net Cash Flow of $2.06 million; for the year ended Dec 31, 2023, it was -$1.07 million.

  • The five-year range for quarterly Net Cash Flow is -$150,000 (the quarter ended Sep 30, 2024) to $1.36 million (the quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -4.12 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -3.52 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 4.21 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.81 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.41 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 3.26 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 843.00 Mn
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 15,000.00
Jun 30, 2025 837,000.00
Mar 31, 2025 1.36 Mn
Sep 30, 2024 -150,000.00
Jun 30, 2024 667,000.00
Mar 31, 2024 701,000.00
API Access

Innocan Pharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=INNPF&period=max&api_key=YOUR_API_KEY